BrainStorm Cell Therapeutics
BCLI
#10526
Rank
โ‚ฌ6.89 M
Marketcap
0,62ย โ‚ฌ
Share price
-6.49%
Change (1 day)
-41.60%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2025 (TTM): -1,32ย โ‚ฌ

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -1,29ย โ‚ฌ. In 2015 the company made an earnings per share (EPS) of -5,86ย โ‚ฌ an increase over its 2014 EPS that were of -8,85ย โ‚ฌ.

EPS history for BrainStorm Cell Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-1,32ย โ‚ฌ
2015-5,86ย โ‚ฌ-33.82%
2014-8,85ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
8,11ย โ‚ฌ-727.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
5,94ย โ‚ฌ-559.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-3,48ย โ‚ฌ 169.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-5,93ย โ‚ฌ 359.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-2,70ย โ‚ฌ 108.72%๐Ÿ‡บ๐Ÿ‡ธ USA